Literature DB >> 19751589

Dengue 1 virus and dengue hemorrhagic fever, French Polynesia, 2001.

Bruno Hubert1, Scott B Halstead.   

Abstract

An epidemic of dengue 1 virus (DENV-1) occurred in French Polynesia in 2001, 4 years after a DENV-2 epidemic that ended in 1997. Surveillance data from hospitalized case-patients showed that case-patients with dengue hemorrhagic fever (DHF) exhibited a bimodal age distribution with 1 peak among infants 6-10 months of age and a second peak at 4-11 years of age. The relative risk of DHF developing in children born before rather than after the DENV-2 epidemic was 186 (95% confidence interval 26-1,324). Among children born toward the end of the DENV-2 epidemic, a strong temporal association was found between the month of birth and the risk of being hospitalized for DHF. This study documents epidemic pathogenicity associated with the sequence of DENV-2 infection followed by DENV-1 infection.

Entities:  

Mesh：

Year:  2009        PMID： 19751589     DOI： 10.3201/eid1508.081500

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  8 in total

1.  Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity.

Authors:  Molly OhAinle; Angel Balmaseda; Alexander R Macalalad; Yolanda Tellez; Michael C Zody; Saira Saborío; Andrea Nuñez; Niall J Lennon; Bruce W Birren; Aubree Gordon; Matthew R Henn; Eva Harris
Journal:  Sci Transl Med       Date:  2011-12-21       Impact factor: 17.956

2.  The incidence, characteristics, and presentation of dengue virus infections during infancy.

Authors:  Rosario Z Capeding; Job D Brion; Mercydina M Caponpon; Robert V Gibbons; Richard G Jarman; In-Kyu Yoon; Daniel H Libraty
Journal:  Am J Trop Med Hyg       Date:  2010-02       Impact factor: 2.345

Review 3.  Protective and enhancing interactions among dengue viruses 1-4 and Zika virus.

Authors:  Leah C Katzelnick; Sandra Bos; Eva Harris
Journal:  Curr Opin Virol       Date:  2020-09-24       Impact factor: 7.090

4.  Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year.

Authors:  Magelda Montoya; Lionel Gresh; Juan Carlos Mercado; Katherine L Williams; Maria José Vargas; Gamaliel Gutierrez; Guillermina Kuan; Aubree Gordon; Angel Balmaseda; Eva Harris
Journal:  PLoS Negl Trop Dis       Date:  2013-08-08

5.  Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection.

Authors:  Thavamalar Balakrishnan; Dennis B Bela-Ong; Ying Xiu Toh; Marie Flamand; Shamala Devi; Mickey B Koh; Martin L Hibberd; Eng Eong Ooi; Jenny G Low; Yee Sin Leo; Feng Gu; Katja Fink
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

6.  Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity.

Authors:  Nicholas G Reich; Sourya Shrestha; Aaron A King; Pejman Rohani; Justin Lessler; Siripen Kalayanarooj; In-Kyu Yoon; Robert V Gibbons; Donald S Burke; Derek A T Cummings
Journal:  J R Soc Interface       Date:  2013-07-03       Impact factor: 4.118

Review 7.  Recent advances in understanding dengue.

Authors:  Scott Halstead
Journal:  F1000Res       Date:  2019-07-31

8.  Dengue serotype cross-reactive, anti-e protein antibodies confound specific immune memory for 1 year after infection.

Authors:  Ying Xiu Toh; Victor Gan; Thavamalar Balakrishnan; Roland Zuest; Michael Poidinger; Solomonraj Wilson; Ramapraba Appanna; Tun Linn Thein; Adrian Kheng-Yeow Ong; Lee Ching Ng; Yee Sin Leo; Katja Fink
Journal:  Front Immunol       Date:  2014-08-14       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.